US Patent Issued to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Aug. 11 for "Enteroendocrine cell-targeting polymer substance conjugated with photosensitizer, and medical use thereof for ameliorating metabolic disease" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,712, issued on Aug. 11, was assigned to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea).

"Enteroendocrine cell-targeting polymer substance conjugated with photosensitizer, and medical use thereof for ameliorating metabolic disease" was invented by Kun Na (Bucheon-si Gyeonggi-do, South Korea) and Sang Hee Lee (Bucheon-si Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A fatty acid-biocompatible polymer-photosensitizer conjugate is provided. The conjugate can kill GIP-secreting cells by generating active oxygen upon irradiation with light, and has the effect of increasing insulin, ...